| # | Drug | Count |
|---|---|---|
| 0 | BLINATUMOMAB | 5 |
| 1 | INTERFERON BETA-1A | 2 |
| 2 | LENALIDOMIDE | 2 |
| 3 | RITUXIMAB | 2 |
| 4 | TAFASITAMAB-CXIX | 2 |
| 5 | TERIFLUNOMIDE | 2 |
| 6 | AXICABTAGENE CILOLEUCEL | 1 |
| 7 | AZITHROMYCIN | 1 |
| 8 | AZITHROMYCIN DIHYDRATE | 1 |
| 9 | AZITHROMYCIN MONOHYDRATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFASITAMAB-CXIX | 2 | 0.0022 |
| 1 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 2 | BLINATUMOMAB | 5 | 0.0005 |
| 3 | GLOFITAMAB | 1 | 0.0004 |
| 4 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 5 | RIFAMPIN | 1 | 0.0001 |
| 6 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 7 | TERIFLUNOMIDE | 2 | 0.0000 |
| 8 | VINCRISTINE SULFATE | 1 | 0.0000 |
| 9 | BELIMUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 2 | Pyrimidine Synthesis Inhibitor [EPC] | 2 | 0.0000 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 5 | Interferon beta [EPC] | 2 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 3 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 8 | Thalidomide Analog [EPC] | 2 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 1 | 0.0000 |